In a study published in the journal Urology this year, the IsoPSA lab-developed test showed it was able to separate out men carrying a lower risk for high-grade prostate cancer, potentially allowing ...

CLEVELAND--(BUSINESS WIRE)--Cleveland Diagnostics, Inc., a pioneering, commercial-stage precision oncology company, announced today that the U.S. Food and Drug Administration (FDA) has approved the ...

According to the institute, a single, reliable test to differentiate aggressive, life-threatening cancers from slower-growing ...

Tumor heterogeneity, which refers to variations in the cellular and genetic components between cancer cells within a tumor, can complicate the determination of optimal treatment approaches for ...

The study's testing accurately identified prostate cancer 91% of the time and accurately ruled out men without prostate cancer 84% of the time. A urine-based biomarker panel may be a promising, ...

The FDA has granted Cleveland Diagnostics’ IsoPSA test premarket approval (PMA) to help detect prostate cancer in men aged 50 years or older with elevated PSA levels. IsoPSA is a blood assay that ...

Prostate biopsies in Florida typically cost between $4,864 and $5,334 per procedure, representing a significant burden when a majority of procedures yield benign findings. If the study’s objectives ...

Ibex Medical Analytics has signed a strategic partnership with US-based HNL Lab Medicine to deploy clinical-grade AI for prostate cancer diagnostics. The collaboration centres on deploying Ibex’s AI ...

The prostate health index (PHI) is a blood test that more accurately assesses the risk of prostate cancer than a traditional PSA test. The PHI combines three different PSA tests to create one risk ...

Please provide your email address to receive an email when new articles are posted on . Use of a precision navigator led to significant increase in genomic profiling among men with prostate cancer.

Researchers from Johns Hopkins Kimmel Cancer Centre, Johns Hopkins All Children's Hospital, and other institutions have developed a new urine-based test to identify prostate cancer, potentially ...